The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome.
Fu CE, Yong JN, Ng CH, Nah B, Chew NWS, Chin YH, Kong G, Tan DJH, Lim WH, Lim LKE, Zeng RW, Shabbir A, Tan EXX, Huang DQ, Khoo CM, Siddqui MS, Chan MYY, Noureddin M, Mamas MA, Muthiah M.
Fu CE, et al. Among authors: mamas ma.
Aliment Pharmacol Ther. 2023 May;57(9):979-987. doi: 10.1111/apt.17397. Epub 2023 Jan 29.
Aliment Pharmacol Ther. 2023.
PMID: 36710531